BPC-157 + TB-500: Research Overview & Handling Guide

What are BPC-157 and TB-500?

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide originally isolated from a protective sequence found in human gastric juice. In laboratory research it is most often studied for its effects on cellular repair pathways, angiogenesis, and connective-tissue models.

TB-500 is a synthetic fragment of the naturally occurring protein Thymosin Beta-4. It has been investigated in preclinical models for its role in actin regulation, cell migration, and vascular formation.

The two are frequently paired in research settings because their study endpoints overlap — angiogenesis, tissue-repair signalling, and inflammation modelling — while their mechanisms are distinct.

Why researchers combine them

Combining BPC-157 and TB-500 in a single research vial reduces the number of reconstitution steps and dosing errors in a study protocol. It also allows a single control arm to compare a combined-peptide condition against each peptide in isolation.

This blend is intended strictly for in-vitro or preclinical animal-model research. It is not a therapeutic product and is not intended for human or veterinary use.

Reconstitution and storage

Lyophilized BPC-157 + TB-500 is typically reconstituted with bacteriostatic water. The volume of diluent controls the final concentration per unit volume; researchers should calculate this based on the endpoint dose the study calls for.

Unreconstituted vials should be stored at or below 4°C, protected from light. Once reconstituted, most published handling notes recommend refrigeration at 2–8°C and use within 30 days, with the vial kept upright and the septum sanitized before each withdrawal.

Purity and documentation

Elite Aminos supplies research peptides intended for laboratory use only. Each lot is manufactured to research-grade purity standards and third-party tested. Certificates of Analysis are available on request for institutional buyers.